Skip to main content
. 2017 Jan 1;31(1):34–45. doi: 10.1101/gad.289728.116

Figure 3.

Figure 3.

PIDDosome-activated p53 shares features with nongenotoxic activation via Nutlin-3 and functions via p21. (A) A549 knockout cells obtained using the indicated sgRNAs were treated with doxorubicin (DXR), nocodazole, or ZM447439 for 24 h and processed for immunoblotting. (B,C) A549 knockout cells obtained using the indicated sgRNAs were treated for the indicated times with Nutlin-3, ZM447439, or ZM447439 followed by the addition of Nutlin-3 and processed for DNA content analysis (B) or immunoblotting (C). (D,E) Following transfection with siRNAs, cells were treated with ZM447439 for 48 h and processed for immunoblotting (D) or DNA content analysis (E).